dsdsa

product

Chinese Professional Crizotinib - High Purity Pharmaceutical Grade 857890-39-2 Lenvatinib mesylate for Cancer Treatment – Yibai

Short Description:


Product Detail

FAQ

Product Tags

Related Video

Feedback (2)

Our enterprise since its inception, usually regards product top quality as business life, repeatedly enhance manufacturing technology, make improvements to product excellent and continuously strengthen enterprise total high quality administration, in strict accordance with all the national standard ISO 9001:2000 for Mdv 3100, 73-31-4, Lorcaserin Hydrochloride, Base on the business concept of Quality first, we would like to meet more and more friends in the word and we hope provide the best product and service to you.
Chinese Professional Crizotinib - High Purity Pharmaceutical Grade 857890-39-2 Lenvatinib mesylate for Cancer Treatment – Yibai Detail:

Product name Lenvatinib mesylate
Synonyms 4-[3-Chloro-4-[[(cyclopropylamino)carbonyl]amino]phenoxy]-7-methoxy-6-quinolinecarboxamide monomethanesulfonate
CAS No. 857890-39-2
Appearance Pale reddish yellow to white crystalline powder
Molecular Formula C21H19ClN4O4.CH4O3S
Molecular Weight 522.96
Usage Research purpose
Packing As per your request
Storage Preserve in tight,light-resistant containers in a cool place

 

Lenvatinib mesylate CAS:857890-39-2

ITEMS

STANDARDS

RESULTS

CHARACTERISTICS

Pale reddish yellow to white crystalline powder

Almost white crystalline powder

IDENTIFICATION

1、By IR2、By HPLC

Complies

SOLUBILITY

Slightly soluble in water;practically insoluble in  ethanol

Complies

WATER

≤1.0%

0.26%

RESIDUE ON IGNITION

≤0.2%

0.08%

HEAVY METALS

≤20ppm

Complies

RELATIVE SUBSTANCE

Any individual impurity:≤0.5 %

0.21%

Total Impurities:≤1.0 %

0.43%

ASSAY 98.0~102.0%

99.3%

Conclusion:It complies to enterprise standard

Company Information

√ Management layer’s full experience in factory and skilled technicians followers;
√ Quality is always our top consideration, Strict QC system;
√ 11 years experienced exporting sales team;
√ Independent R&D lab;
√ Two signed long term GMP workshops;
√ Rich resources of plenty idle factories for customized project;
√ High Efficiency working team with consistent path.
imgsafSDGSHDASFG

Product detail pictures:


Related Product Guide:

With advanced technologies and facilities, strict high quality regulate, reasonable price tag, excellent support and close co-operation with shoppers, we have been devoted to furnishing the best benefit for our buyers for Chinese Professional Crizotinib - High Purity Pharmaceutical Grade 857890-39-2 Lenvatinib mesylate for Cancer Treatment – Yibai , The product will supply to all over the world, such as: Mexico, Swedish, Milan, We solution have passed through the national skilled certification and been well received in our key industry. Our specialist engineering team will often be ready to serve you for consultation and feedback. We've been able to also provide you with no cost samples to meet your needs. Best efforts are going to be produced to supply you the very best service and solutions. For anyone who is considering our business and solutions, please speak to us by sending us emails or get in touch with us right away. As a way to know our items and enterprise. lot more, you'll be able to come to our factory to find out it. We'll constantly welcome guests from around the globe to our firm. o build enterprise. elations with us. You should really feel absolutely free to make contact with us for small business and we believe we'll share the top trading practical experience with all our merchants.
The company can think what our think, the urgency of urgency to act in the interests of our position, can be said this is a responsible company, we had a happy cooperation!
5 Stars By Ann from Puerto Rico - 2017.01.28 18:53
Company director has very rich management experience and strict attitude, sales staff are warm and cheerful, technical staff are professional and responsible,so we have no worry about product,a nice manufacturer.
5 Stars By trameka milhouse from Nigeria - 2018.03.03 13:09
Write your message here and send it to us